共查询到20条相似文献,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
Lucchina S Badia A Nistor A Fusetti C 《Plastic and reconstructive surgery》2011,128(2):599-600; author reply 600
7.
8.
9.
10.
Conservative treatment of cutis aplasia 总被引:1,自引:0,他引:1
Three cases of cutis aplasia are presented. The defects involved include full-thickness defects of scalp and cranium as well as full-thickness skin defects of the abdomen and thigh. All patients were treated conservatively with the use of Silvadene cream dressings. Healing was obtained in all patients. 相似文献
11.
S Filipecki A Pietraszek M Szturmowicz W Tomkowski W Pokojski A Fija?kowska D Szymańska 《Polski tygodnik lekarski (Warsaw, Poland : 1960)》1990,45(45-46):894-898
Methods and results of both conservative and invasive therapy of pericarditis were analysed in the group of 30 patients. An emphasis was on successful treatment of mild (idiopathic) pericarditis and efficiency of the early started, combined pharmacotherapy (tuberculostatics + corticosteroids) of pericarditis of tuberculous etiology. A stress is on marked immediate efficacy of surgery in case of cardiac tamponade, independent on its etiology, with simultaneous recommendation of ultrasound-guided pericardial sac paracentesis. Survival rate in patients with malignant pericarditis is relatively low. 相似文献
12.
13.
14.
15.
16.
Alessandro Bovicelli Giuseppina D'Andrilli Antonio Giordano Pierandrea De Iaco 《Journal of cellular physiology》2013,228(6):1154-1158
Endometrial cancer is the most common cancer of the female genital tract in Europe and in the United States. Endometrial cancer has increased 21% in incidence since 2008, and the death rate has increased more than 100% over the past two decades. Approximately 15% of patients with endometrial cancer are pre‐menopausal. The aim of this review is to discuss the conservative management of endometrial cancer. A number of studies largely support the conservative treatment of endometrial carcinoma (EC) in women desiring future fertility. We focus on the role of progestin hormonal therapy, including the risks associated with non‐standard care, appropriate candidate selection, expected outcomes, various progestin agents and recommended follow‐up. J. Cell. Physiol. 228: 1154–1158, 2013. © 2012 Wiley Periodicals, Inc. 相似文献
17.
18.
19.